Resultados: 19

Early antiretroviral therapy initiation: access and equity of viral load testing for HIV treatment monitoring

Lancet, Infect. dis.; 17 (1), 2017
Scaling up access to HIV viral load testing for individuals undergoing antiretroviral therapy in low-resource settings is a global health priority, as emphasised by research showing the benefits of suppressed viral load for the individual and the whole population. Historically, large-scale diagnostic tes...

Effect of Different Types of Exercise in HIV + Mozambican Women Using Antiretroviral Therapy

Open AIDS j; 9 (1: M5), 2015
The aim of this study was to evaluate and compare the effect of two types of exercises interventions on the regularity and health-related physical fitness in HIV-infected individuals who use antiretroviral therapy (ART). A total of 53 HIV+ African women (mean age=39.5±8.4 years) on ART participated in t...

Post-ART Symptoms Were Not the Problem: A Qualitative Study on Adherence to ART in HIV-Infected Patients in a Mozambican Rural Hospital

PLos ONE; 10 (9), 2015
Objective: The objective of this qualitative study was to explore how clinical symptoms may affect adherence to antiretroviral therapy (ART) in HIV patients, and to explore factors, perceptions and attitudes related to adherence to therapy. Design: A qualitative study was carried out in the context of th...

Trends in Prevalence of HIV-1 Drug Resistance in a Public Clinic in Maputo, Mozambique

PLos ONE; 10 (7), 2015
Background: An observational study was conducted in Maputo, Mozambique, to investigate trends in prevalence of HIV drug resistance (HIVDR) in antiretroviral (ART) naïve subjects initiating highly active antiretroviral treatment (HAART). Methodology/principal findings: To evaluate the pattern of drug res...

Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship

J. antimicrob. chemother; 70 (1), 2015
Objectives: We describe nevirapine and efavirenz exposure on and off tuberculosis treatment and consequences for virological efficacy and tolerance in patients included in the ANRS 12146/12214-CARINEMO trial. Methods: Participants were randomly selected to receive either nevirapine at 200 mg twice daily...

Evolution of primary HIV drug resistance in a subtype C dominated epidemic in Mozambique
Evolution of primary HIV drug resistance in a subtype C dominated epidemic in Mozambique

PLos ONE; 8 (7), 2013
Em Moçambique, o tratamento anti-retroviral altamente activo (HAART) foi introduzido em 2004, seguido de descentralização e expansão, resultando num aumento de mais de 20 vezes na cobertura até 2009. A implementação de inquéritos sobre limiares de resistência aos medicamentos contra o VIH (HIVDR...

Evolution of primary HIV drug resistance in a subtype C dominated epidemic in Mozambique

PLos ONE; 7 (9), 2012
Objective: InMozambique, highly active antiretroviral treatment (HAART) was introduced in 2004 followed by decentralizationandexpansion, resulting inamorethan20-fold increase incoverageby2009. ImplementationofHIV drugresistancethresholdsurveys (HIVDR-TS) iscrucial inorder tomonitor theemergenceof transmi...

Quality of HIV care provided by non-physician clinicians and physicians in Mozambique: a retrospective cohort study

AIDS (Lond.); 24 (1), 2012
Objectives: To compare HIV care quality provided by non-physician clinicians (NPC) and physicians. Design: Retrospective cohort study assessing the relationship between provider cadre and HIV care quality among non-pregnant adult patients initiating antiretroviral therapy (ART) in the national HIV care ...

Treatment of Kaposi sarcoma in human immunodeficiency virus-1-infected Mozambican children with antiretroviral drugs and chemotherapy

Pediatr. infect. dis. j; 30 (10), 2011
AIDS-associated Kaposi sarcoma occurs in children, but treatment experience reports are very scarce. A retrospective analysis of 28 children treated with highly active antiretroviral therapy and monthly paclitaxel showed unexpected results with 19 children in complete and sustainable remission, including...